Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
INKT holding history
MiNK Therapeutics, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INKT overviewAll 13F holders of INKTFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −15,322−100.0% | Sold out | Holders |
| Q3 2024 | 15,322 | $11.5K | <0.1% | −20,407−57.1% | Reduced | Holders |
| Q2 2024 | 35,729 | $33.9K | <0.1% | −18,562−34.2% | Reduced | Holders |
| Q1 2024 | 54,291 | $49.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 54,291 | $58.1K | <0.1% | −7,508−12.1% | Reduced | Holders |
| Q3 2023 | 61,799 | $68.0K | <0.1% | +22,257+56.3% | Added | Holders |
| Q2 2023 | 39,542 | $83.0K | <0.1% | +39,542 | New | Holders |